Providence Cancer Institute is a clinical research site located in Southfield, Michigan, United States 48075.
Crixeo Clinical Trials Trust Score: 18/100 (FAILING). This profile has not yet been claimed by the site owner.
Providence Cancer Institute has participated in 12 clinical trials with 1 currently active.
Therapeutic areas: Squamous Cell Non-small Cell Lung Cancer, Chronic Myeloid Leukemia, Non-Small Cell Lung Cancer.
Sponsors: Bristol-Myers Squibb, Ariad Pharmaceuticals, St. John Providence Health System.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Michigan · View every site in Southfield
Trust Score: 18/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Providence Cancer Institute has a Crixeo Trust Score of 18/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Providence Cancer Institute has 12 clinical trials on record, with 1 currently active. Their work covers Squamous Cell Non-small Cell Lung Cancer, Chronic Myeloid Leukemia, Non-Small Cell Lung Cancer.
Providence Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.